
PF-03382792
CAS No. 1400811-63-3
PF-03382792( PF-3382792 )
Catalog No. M11670 CAS No. 1400811-63-3
PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 540 | Get Quote |
![]() ![]() |
10MG | 770 | Get Quote |
![]() ![]() |
25MG | 1152 | Get Quote |
![]() ![]() |
50MG | 1575 | Get Quote |
![]() ![]() |
100MG | 2124 | Get Quote |
![]() ![]() |
500MG | 4257 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePF-03382792
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.
-
DescriptionPF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.Other Indication Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsPF-3382792
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number1400811-63-3
-
Formula Weight433.52
-
Molecular FormulaC23H32FN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N1C(C(C)(C)C2=C1C=C(F)C=C2)=O)NCC3CCN(CC4(O)CCOCC4)CC3
-
Chemical Name1H-Indole-1-carboxamide, 6-fluoro-2,3-dihydro-3,3-dimethyl-2-oxo-N-((1-((tetrahydro-4-hydroxy-2H-pyran-4-yl)methyl)-4-piperidinyl)methyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
YAP-TEAD-IN-3
YAP-TEAD-IN-3 is an inhibitor of YAP/TAZ-TEAD interactions with an IC50 of 9 nM for Avi-human TEAD (4217-434).
-
Methyl pentadecanoat...
Methyl pentadecanoate is a natural product.Methyl pentadecanoate is a saturated fatty acid methyl ester obtained from the esterification of myristic acid. Methyl myristate shows a high melanin induction in B16F10 melanoma.
-
Bis-Tos-PEG4
Bis-Tos-PEG4 (PROTAC Linker 16) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.